Company profile
Hepion Pharmaceuticals, Inc. Insider Trading
HEPAEvery SEC Form 4 insider trading filing for Hepion Pharmaceuticals, Inc. (HEPA) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- OTC
- Sector
- Pharmaceutical Preparations
- CIK
- 0001583771
- Filings
- 27
- Insiders
- 14
- Last filing
- 2026-09-03
Activity summary
Recent insider activity is bullish. Over the last 30 days, 1 insider purchased shares. Buying was led by Vincent S LoPriore.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Hepion Pharmaceuticals, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $825K.
90 day insight
Over the last 90 days, Hepion Pharmaceuticals, Inc. insiders bought $825K across 21 transactions with no open-market sales.
- Most active insider: Vincent S LoPriore with 6 transactions totaling $500K.
- Largest single purchase: $400K by Vincent S LoPriore on Aug 3, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Vincent S LoPriore | HEPA | Purchase | 12,500,000 | — | — |
| Aug 19, 2026 | Gary S. Stetz II | HEPA | Award | 299,000 | — | — |
| Aug 19, 2026 | Sireesh Appajosyula | HEPA | Award | 1,345,500 | — | — |
| Aug 19, 2026 | James Gordon Liddy | HEPA | Award | 299,000 | — | — |
| Aug 19, 2026 | Danina Fisher | HEPA | Award | 299,000 | — | — |
34 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=HEPA" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.